Warren Urges Government to Seize Patents on Pfizer’s Cancer Drug

Pfizer Inc.‘s prostate cancer medicine Xtandi is in the crosshairs of a growing campaign for the government to seize patent rights to bolster competition.

Sen. Elizabeth Warren (D-Mass.) and two other lawmakers are pushing the Biden administration to take unilateral action to lower the price of the drug, pointing to a decades-old law that lets the government leverage “march-in rights” to license patents on certain medicines to outside manufacturers.

“We urge you to use existing executive authority to deliver meaningful relief to consumers,” Warren wrote in a Thursday letter to Health and Human Services Secretary Xavier Becerra. Doing so ...